External medicine for diffuse plexiform neurofibroma
AssigneeOsaka University
InventorsMari Kaneda, Ichiro Katayama
Life of this patent
Estimating the term…
Abstract
An external medicine for diffuse plexiform neurofibromas is provided. The external medicine for diffuse plexiform neurofibromas in accordance with an embodiment of the present invention contains, as an active ingredient, at least one selected from the group consisting of sirolimus and sirolimus derivatives.
Claims5
An external medicine for neurofibromas, comprising, (i) as an active ingredient, at least one selected from the group consisting of sirolimus, everolimus, temsirolimus, ridaforolimus, and zotarolimus and (ii) ethanol,
- the ethanol being contained in an amount of 20 wt % to 60 wt %,
- the active ingredient being contained in an amount of not less than 0.2 wt % and less than 0.8 wt %.
A method of performing a medical procedure or medical treatment for neurofibromas, comprising the step of administering an external medicine comprising, (i) as an active ingredient, at least one selected from the group consisting of sirolimus, everolimus, temsirolimus, ridaforolimus, and zotarolimus and (ii) ethanol,
- the ethanol being contained in an amount of 20 wt % to 60 wt %,
- the active ingredient being contained in an amount of not less than 0.2 wt % and less than 0.8 wt %.
Dependencies are inferred from the claim text.